Han et al. (2019) reported that the loss of the reader YTHDF1 in dendritic cells restricted the expression of lysosomal proteases, promoted cross‐presentation of tumor antigens, improved cross‐priming of CD8+ T cells, and enhanced therapeutic efficacy of PD‐L1 blockade. Here, YTHDF1 is linked to neoplasm.